Literature DB >> 12861124

Cancer from an unknown primary site.

Jonathan E Dowell.   

Abstract

Cancer from an unknown primary site (CUP) is frequently encountered in clinical practice. This review is designed to help physicians identify those patients with CUP that benefit from specific therapeutic approaches. The utility of pathologic and diagnostic tests in patients with CUP will also be discussed, as will the prognosis and appropriate treatment of these patients.

Entities:  

Mesh：

Year:  2003        PMID： 12861124     DOI： 10.1097/00000441-200307000-00006

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  5 in total

Review 1.  [The initial CUP situation and CUP syndrome: pathological diagnostics].

Authors:  R Moll
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

Review 2.  Molecular imaging of metastatic potential.

Authors:  Paul T Winnard; Arvind P Pathak; Surajit Dhara; Steven Y Cho; Venu Raman; Martin G Pomper
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

3.  92-Gene molecular profiling in identification of cancer origin: a retrospective study in Chinese population and performance within different subgroups.

Authors:  Fei Wu; Dan Huang; Lisha Wang; Qinghua Xu; Fang Liu; Xun Ye; Xia Meng; Xiang Du
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

4.  Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer.

Authors:  Anand Kulkarni; Raji Pillai; Ashley M Ezekiel; W David Henner; Charles R Handorf
Journal:  Diagn Pathol       Date:  2012-08-21       Impact factor: 2.644

5.  Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.

Authors:  Yuekai Li; Fengcai Li; Xin Li; Lili Qu; Jiankui Han
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.